XML 71 R38.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Benefit Plans (Tables)
9 Months Ended
Jul. 31, 2024
Benefit Plans  
Schedule of Share-Based Compensation Reflected in Consolidated Statement of Operations and Comprehensive Loss

Share-based compensation was reflected in the Consolidated Statements of Operations and Comprehensive Loss as follows (in thousands):

Three Months Ended July 31,

Nine Months Ended July 31,

    

2024

    

2023

2024

    

2023

Cost of revenues

$

463

$

389

$

1,211

$

1,137

Administrative and selling expense

2,304

2,285

6,498

6,546

Research and development expense

483

375

1,257

1,034

$

3,250

$

3,049

$

8,966

$

8,717

Summary of RSU Activity

The following table summarizes our RSU activity for the nine months ended July 31, 2024:

Restricted Stock Units

    

Shares

    

Weighted-Average Fair Value

Outstanding as of October 31, 2023

6,543,138

$

5.06

Granted - time-vesting RSUs

9,419,684

1.27

Granted - PSUs

3,274,384

1.63

Vested

(2,273,544)

7.03

Forfeited

(191,243)

3.19

Outstanding as of July 31, 2024

16,772,419

$

2.15